SCHEMBL7930934

SCHEMBL7930934

Nc1nc(Cl)nc2c(N)ncnc12

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDK1 P06493 2/20 0.43
PI4KA P42356 2/20 0.36
PI4K2B Q8TCG2 2/20 0.36
PI4K2A Q9BTU6 2/20 0.36
PI4KB Q9UBF8 2/20 0.36
ADORA2A P29274 4/20 0.35
ADORA1 P30542 4/20 0.35
ADORA2B P29275 3/20 0.35
MAP4K4 O95819 6/20 0.35
CSNK1A1 P48729 2/20 0.34
CLK4 Q9HAZ1 2/20 0.34
ADORA3 P0DMS8 2/20 0.33
PDE5A O76074 1/20 0.33
CDC7 O00311 1/20 0.33
PLK4 O00444 1/20 0.33
AURKA O14965 1/20 0.33
DAPK3 O43293 1/20 0.33
DYRK3 O43781 1/20 0.33
ROCK2 O75116 1/20 0.33
PRKD3 O94806 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10104557 0.85 CDK1 (0.42) CDK1ADORA2AADORA1CSNK1A1CLK4
SCHEMBL22715140 0.82 CDC7 (0.38) CDK1PI4KAPI4K2BPI4K2API4KB
SCHEMBL29439775 0.82 CDC7 (0.38) CDK1PI4KAPI4K2BPI4K2API4KB
SCHEMBL7938941 0.81 CDK1 (0.45) CDK1ADORA2AADORA1CSNK1A1CLK4
SCHEMBL7938906 0.77 ADORA2A (0.45) CDK1PI4KAPI4K2BPI4K2API4KB
SCHEMBL22715904 0.72 ADORA2A (0.39) PI4KAPI4K2BPI4K2API4KBADORA2A
SCHEMBL29439732 0.72 ADORA2A (0.39) PI4KAPI4K2BPI4K2API4KBADORA2A
SCHEMBL6359268 0.72 CDK1 (0.39) CDK1CSNK1A1CLK4
SCHEMBL22715627 0.71 ADORA2A (0.37) PI4KAPI4K2BPI4K2API4KBADORA2A
SCHEMBL29439817 0.71 ADORA2A (0.37) PI4KAPI4K2BPI4K2API4KBADORA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6232312-B1 ADMINISTERING A COMBINATION OF INDENE AND PYRIMIDO(5,4-D)PYRIMIDINE DERIVATIVES TO TREAT PREPANCREATIC CANCER CELL PATHWAYS, INC. 2001-05-15 US disclosed